Copyright
©The Author(s) 2021.
World J Gastrointest Pathophysiol. May 22, 2021; 12(3): 51-58
Published online May 22, 2021. doi: 10.4291/wjgp.v12.i3.51
Published online May 22, 2021. doi: 10.4291/wjgp.v12.i3.51
Table 2 Predictors of cytomegalovirus infection after liver transplantation
| CMV (%) | No CMV (%) | RR (95%CI) | P value | |
| Number of patients (%) | 16/68 (23.5) | 52/68 (76.5%) | ||
| CMV reactivation before transplantation | 7/16 (43.8) | 15/52 (28.8) | 1.91 (0.6-6.1) | 0.265 |
| Quantitative PCR pre-transplant (IU/mL), mean (SD) | 2862 (5696) | 868 (2756) | NA | 0.154 |
| Gender (male) | 4/16 (25) | 16/52 (30.8) | 0.75 (0.2-2.7) | 0.762 |
| Mean age, years (SD) | 55 (10.3) | 57.3 (8) | NA | 0.373 |
| MELD score, median (IqR) | 11 (4) | 12 (11) | NA | 0.254 |
| Lymphocyte count, median (IqR) | 1101 (1109) | 918 (754) | NA | 0.580 |
| Organ rejection | 3/16 (18.7) | 8/52 (15.3) | 1.27 (0.3-5.5) | 0.716 |
| CMV-negative receptor | 3/16 (18.7) | 1/52 (1.9) | 11.7 (1.1-122.6) | 0.038 |
| Hepatitis C infection | 9/16 (56.2) | 34/52 (65.4) | 0.7 (0.2-2.1) | 0.508 |
| Hepatitis B infection | 1/16 (6.2) | 4/52 (7.7) | 0.8 (0.1-7.1) | 0.100 |
| Hepatocarcinoma | 9/16 (56.2) | 30/52 (57.7) | 0.9 (0.3-2.9) | 0.919 |
| Fulminant hepatitis | 0 | 1/52 (1.9) | NA | NA |
| Diabetes mellitus | 6/16 (37.5) | 16/52 (30.8) | 1.3 (0.4-4.3) | 0.615 |
| Renal failure | 2/7 (12.5) | 5/52 (9.6) | 1.3 (0.2-7.7) | 0.664 |
| Re-transplantation | 1/16 (6.2) | 1/52 (1.9) | 3.4 (0.2-57.7) | 0.418 |
- Citation: Stadnik CMB, Caurio CFB, Rodrigues-Filho EM, Nedel WL, Cantisani GP, Zanotelli ML, Pasqualotto AC. Impact of cytomegalovirus reactivation just before liver transplantation: A prospective cohort study. World J Gastrointest Pathophysiol 2021; 12(3): 51-58
- URL: https://www.wjgnet.com/2150-5330/full/v12/i3/51.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v12.i3.51